Eric H. Schoenstein
Jensen Investment Management
Eric H. Schoenstein IDEXX Laboratories Inc stake
total: 257
Jensen Investment Management IDXX trades
- Total transactions:
- 9
- New positions:
- 1
- Added:
- 4
- Reduced:
- 4
- Held since:
- 2024 Q2
- Held for:
- 9 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Eric H. Schoenstein holds 105,709 IDEXX Laboratories Inc (IDXX) shares with a market value of roughly $55.65M accounting for 1.35% of the overall portfolio. To date, the estimated cost basis is nearly $523.38 for "buy" trades and estimated average "sell" price is $619.4. Jensen Investment Management first purchased IDXX in 2024 Q2, initially acquiring 5,120 shares. Since the initial investment in IDEXX Laboratories Inc (IDXX), Jensen Investment Management has made 8 more transactions.
When did Eric H. Schoenstein buy IDEXX Laboratories Inc (IDXX)?
Eric H. Schoenstein first invested in IDEXX Laboratories Inc (IDXX) in 2024 Q2 at the reported quarter-end price of $487.20 per share.
What's the cost basis of Jensen Investment Management's IDXX stake?
The estimated cost basis for IDEXX Laboratories Inc (IDXX) stake is around $523.38 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $523.38
- Weighted AVG sell price:
- $619.40
Eric H. Schoenstein's historical trades in IDEXX Laboratories Inc
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.35%
|
105,709
|
$526.44
|
$55,649,446
|
+2,861.04% (+102,139)
|
+1.3%
|
|
2026 Q1
|
0.04%
|
3,570
|
$561.89
|
$2,005,947
|
-0.03% (-1)
|
-0%
|
|
2025 Q4
|
0.04%
|
3,571
|
$676.53
|
$2,415,889
|
-19.39% (-859)
|
-0.01%
|
|
2025 Q3
|
0.04%
|
4,430
|
$638.89
|
$2,830,283
|
-57.44% (-5,980)
|
-0.04%
|
|
2025 Q2
|
0.07%
|
10,410
|
$536.34
|
$5,583,299
|
+27.11% (+2,220)
|
+0.01%
|
|
2025 Q1
|
0.04%
|
8,190
|
$419.95
|
$3,439,391
|
-9.20% (-830)
|
-0%
|
|
2024 Q4
|
0.03%
|
9,020
|
$413.44
|
$3,729,229
|
+11.50% (+930)
|
+0%
|
|
2024 Q3
|
0.03%
|
8,090
|
$505.22
|
$4,087,230
|
+58.01% (+2,970)
|
+0.01%
|
|
2024 Q2
|
0.02%
|
5,120
|
$487.20
|
$2,494,464
|
new
|
+0.02%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.